Veeva Link Key People
Deep KOL Data for Better Engagement
Link Key People provides deep data about key opinion leaders (KOLs) and applications to surface relevant insights. Medical and commercial teams use the product to identify KOLs, view their activities, and receive notifications. Analytics teams use Link data to inform targeting and segmentation.
Curated KOL profiles include publications, clinical trials, conferences, associations, guidelines, grants, payments, social media, and news mentions as well as patient mix by disease and drug class in the US. Data is sourced from over 250k public sources, including PubMed, conference websites, digital posts, and other social media feeds.
Customers access the data via a web application, mobile app, APIs, and connectors to CRM and Events Management. The product is available across 85+ countries and all major therapeutic areas.
Announced 2020 Status Mature Customers 100+
Hear How Customers Innovate with Link
Overview
Deep KOL Data for Better Engagement
Link Key People provides deep data about key opinion leaders (KOLs) and software to surface relevant insights. Medical and commercial teams use the product to identify KOLs, view their activities, and receive notifications. Analytics teams use Link data to inform targeting and segmentation.
Curated KOL profiles include publications, clinical trials, conferences, associations, guidelines, grants, payments, social media, and news mentions as well as patient mix by disease and drug class in the US. Data is sourced from over 250k public sources, including PubMed, conference websites, digital posts, and other social media feeds.
Customers access the data via a web application, mobile app, APIs, and connectors to CRM and Events Management. The product is available across 85+ countries and all major therapeutic areas.
Momentum
The industry trusts Link
15/20
top biopharmas use
Link Key People
13/20
top biopharmas standardized across TAs
95%
renewal rate
Why Link Key People
Better KOL engagement
Customer Success
Trusted by biopharmas,
large and small
[Advanz]
[Alexion]
[Astellas]
[Bayer]
[Biogen]
[Daiichi]
[Genmab]
[GSK]
[Idorsia]
[Jazz]
[LEO]
[Lundbeck]
[Menarini]
[Merck]
[Novo-Nordisk]
[Oyster-Point]
[Paratek]
[Pfizer]
[Sanofi]
[Shionogi]
[UCB]
[United]